JNJ Q2 2024 Sales Surge to $22.4 Billion, Beating Expectations

Johnson & Johnson (NYSE: JNJ) reported a 4.3% increase in sales to $22.4 billion in Q2 2024, with operational growth at 6.6% and adjusted EPS rising by 10.2% to $2.82. source: https://tokenist.com/jnj-q2-2024-sales-surge-to-22-4-billion-beating-expectations/?utm_source=rss&utm_medium=rss&utm_campaign=jnj-q2-2024-sales-surge-to-22-4-billion-beating-expectations